|
Dr. Trent is the President and Scientific Director of TGen and is responsible for managing the facilities, staff, programs, commitments, and finances of the Institute. As Chief Scientific Officer, Dr. Trent is also responsible for providing scientific design, direction and oversight of TGen's research programs. After completing a postdoctoral fellowship in 1980 under the guidance of Sydney E. Salmon, M.D., Dr. Trent spent a decade establishing his career at the University of Arizona. While with the University of Arizona, Dr. Trent rose to the rank of Associate Professor within the Department of Medicine at the College of Medicine, and became the first Associate Director for basic sciences at the University of Arizona Cancer Center. He also served as a Member of the Cancer Biology Graduate Program, the Graduate Committee on Genetics, and the Molecular Biology Graduate Program. In 1990, Dr. Trent was named the Emanuel N. Maisel Professor of Oncology and Professor of Radiation Oncology and Human Genetics at the University of Michigan, Ann Arbor. In addition, he served as Professor and Director for the Division of Cancer Biology, Department of Oncology, School of Medicine; Professor of Human Genetics, School of Medicine; and as the Deputy Director and Director of Basic Research of the University of Michigan Comprehensive Cancer Center in Ann Arbor. While at Michigan, Dr. Trent's research efforts received nearly $12 million in external funding. In 1993, Dr. Trent joined the National Institutes of Health (NIH) in Bethesda, Maryland, where he established and served as the founding Director of the Division of Intramural Research (DIR) of the National Human Genome Research Institute (NHGRI). He also established the Cancer Genetics Branch and served as its Chief until his recruitment to head TGen. | 